These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15849934)

  • 41. Neutrophils vs. amoebas: Immunity against the protozoan parasite Entamoeba histolytica.
    Rosales C
    J Leukoc Biol; 2021 Dec; 110(6):1241-1252. PubMed ID: 34085314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolation of phage mimotopes mimicking a protective epitope of GPI-linked proteophosphoglycan antigens of Entamoeba histolytica.
    Melzer H; Felici F; Mansouri E; Fortugno P; Marinets A; Wiedermann G; Kollaritsch H; von Specht B; Duchêne M
    Arch Med Res; 2000; 31(4 Suppl):S309-10. PubMed ID: 11070328
    [No Abstract]   [Full Text] [Related]  

  • 43. [The size of Entamoeba histolytica, Entamoeba coli and Giardia lamblia cysts].
    Lian WN
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1984; 2(4):275. PubMed ID: 6097375
    [No Abstract]   [Full Text] [Related]  

  • 44. Proceedings: An evaluation of the absorption spectra of antigens from Entamoeba histolytica (Ibadan strains).
    Abioye AA
    West Afr J Pharmacol Drug Res; 1974 Dec; 2(1):65P. PubMed ID: 4377832
    [No Abstract]   [Full Text] [Related]  

  • 45. Seroprevalence of Entamoeba histolytica infection in HIV-infected patients in China.
    Chen Y; Zhang Y; Yang B; Qi T; Lu H; Cheng X; Tachibana H
    Am J Trop Med Hyg; 2007 Nov; 77(5):825-8. PubMed ID: 17984335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Entamoeba histolytica antigens as possible vaccinogens? A short review.
    Ahmad S; Khan HM; Mahdi AA; Kumar H; Khan N
    J Chromatogr; 1988 May; 440():467-72. PubMed ID: 2900249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of normal and preeclamptic plasma on superoxide-anion production of neutrophils from healthy non-pregnant women.
    Lampé R; Szucs S; Ormos M; Adány R; Póka R
    J Reprod Immunol; 2008 Oct; 79(1):63-9. PubMed ID: 18538415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of antigens from membrane and soluble fractions of Entamoeba histolytica.
    Mathews HM; Moss DM; Visvesvara GS
    J Protozool; 1986 Aug; 33(3):328-34. PubMed ID: 2875181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Utility and limitations of laboratory diagnosis of amebiasis].
    Merens A; Rapp C; Fabre R; Cavallo JD
    Med Trop (Mars); 2005; 65(2):167-75. PubMed ID: 16038358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-proteinase 3 antibodies both stimulate and prime human neutrophils.
    Uriarte SM; McLeish KR; Ward RA
    Nephrol Dial Transplant; 2009 Apr; 24(4):1150-7. PubMed ID: 18952697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitogenic factor for T inducer/helper cells in Entamoeba histolytica extracts.
    Chen ZC; Herrmann F; Koleski F; Diamantstein T
    Acta Acad Med Wuhan; 1985; 5(4):213-6. PubMed ID: 2882454
    [No Abstract]   [Full Text] [Related]  

  • 52. Cross-reaction of antiserum against enterobacterial common antigen with Entamoeba histolytica HK-9 extracts.
    García-Tamayo F; Carrillo J; Drago-Serrano E; Avila M
    Arch Invest Med (Mex); 1982; 13(4):245-8. PubMed ID: 6295298
    [No Abstract]   [Full Text] [Related]  

  • 53. Release of superoxide anion from polymorphonuclear leukocytes stimulated by rubella viral antigen-antibody complex in vitro.
    Kimura H; Minakami H; Ohbuchi M; Yamaki N; Tsuchida S; Kanazawa K; Hara Y; Asahina J; Abe O; Ike Y; Kurashige S; Otsuki K
    Acta Virol; 1997 Dec; 41(6):329-32. PubMed ID: 9607091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infection by human immunodeficiency virus-1 is not a risk factor for amebiasis.
    Morán P; Ramos F; Ramiro M; Curiel O; González E; Valadez A; Gómez A; García G; Melendro EI; Ximénez C
    Am J Trop Med Hyg; 2005 Aug; 73(2):296-300. PubMed ID: 16103593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Further contribution to the study of the antigenic structure of E. histolytica].
    Gabbrielli G; Buzzanca E
    Boll Soc Ital Biol Sper; 1968 Apr; 44(8):728-9. PubMed ID: 4302159
    [No Abstract]   [Full Text] [Related]  

  • 56. CD59 (protectin) molecule, resistance to complement, and virulence of Entamoeba histolytica.
    Flores-Romo L; Tsutsumi V; Estrada-García T; Shibayama M; Aubry JP; Bacon KB; Martínez-Palomo A
    Trans R Soc Trop Med Hyg; 1994; 88(1):116-7. PubMed ID: 7512288
    [No Abstract]   [Full Text] [Related]  

  • 57. Complement activation by antigenic fractions of Entamoeba histolytica.
    Meri S; Richaud G; Linder E
    Parasite Immunol; 1985 Mar; 7(2):153-64. PubMed ID: 2860628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigen fraction from Entamoeba histolytica strain HK9 for use in ELISA.
    Grundy MS
    Arch Invest Med (Mex); 1982; 13 Suppl 3():249-53. PubMed ID: 6295316
    [No Abstract]   [Full Text] [Related]  

  • 59. Entamoeba histolytica L220 induces the in vitro activation of macrophages and neutrophils and is modulated by neurotransmitters.
    Villalobos-Gómez FDR; García-Lorenzana M; Escobedo G; Talamás-Rohana P; Salinas-Gutiérrez R; Hernández-Ramírez VI; Sánchez-Alemán E; Campos-Esparza MDR; Muñoz-Ortega MH; Ventura-Juárez J
    Acta Parasitol; 2018 Jun; 63(2):270-279. PubMed ID: 29654688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of electromagnetic waves on the growth of Entamoeba histolytica and Entamoeba dispar.
    Aksoy U; Sahin S; Ozkoc S; Ergor G
    Saudi Med J; 2005 Sep; 26(9):1388-90. PubMed ID: 16155653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.